Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06559735 · ClinicalTrials.gov registry record · NA

Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation

A NA study of Chronic Pain, sponsored by CereVu Medical.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06559735 is a NA study of Chronic Pain that is actively recruiting participants, run by CereVu Medical. The registered enrollment target is 25 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06559735, a NA study of Chronic Pain, is actively recruiting participants, sponsored by CereVu Medical.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the study is to determine changes in cerebral nociceptive hemodynamic response (blood oxygenation/flow) before, during and following spinal cord stimulation (SCS). Objective measurements of cerebral nociceptive hemodynamic responses will be obtained with the CereVu sensor and ROPA system and will be analyzed offline and compared against subjective measures of pain. Proprietary analysis algorithms will be incorporated and developed to understand how the objective measurements correlate with subject reported pain levels

Conditions Studied

Interventions

  • DEVICE CereVu Device

Study Locations (1)

California

  • Boomerang Healthcare - Walnut Creek

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-08-13
Est. Completion 2025-03-31
Phase NA

Sponsor

CereVu Medical

2 total trials

What the Registry Record Tells You About NCT06559735

The ClinicalTrials.gov registry entry for NCT06559735 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The listed sponsor is CereVu Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which CereVu Device is the first listed.

NCT06559735 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06559735 about?

NCT06559735 is a clinical study titled "Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation". The primary objective of the study is to determine changes in cerebral nociceptive hemodynamic response (blood oxygenation/flow) before, during and following spinal cord stimulation (SCS). Objective measurements of cerebral nociceptive hemodynamic responses will be obtained with the CereVu sensor an...

What is the current status of trial NCT06559735?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-08-13. Estimated completion is 2025-03-31.

What conditions does trial NCT06559735 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06559735?

The interventions under investigation include: CereVu Device (DEVICE).

Who is sponsoring clinical trial NCT06559735?

This trial is sponsored by CereVu Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06559735 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.